Experimental

The US Food and Drug Administration has issued its first comprehensive guide on how psychedelic drugs should be studied in trials, signalling a shift toward recognizing the potential of these therapeutics and what's needed to see them approved.

A new treatment has shown promise in reducing migraine pain with targeted ear acupuncture, opening the door to therapy that could be used as a complementary procedure alongside existing medication prescribed to those with the debilitating condition.

In the early hours of Friday, July 10, a team of researchers dropped the world's first general-purpose biomedical AI agent, which has the power to autonomously complete complex tasks that would take a team of scientists days, if not weeks, to do.

Peptide may not yet be the 2026 Oxford Word of the Year, but it must surely be in the running. For those of us not immersed in this new form of chemical pop culture, what the heck are they, and what should you be aware of if you're peptide-curious?

A novel three-in-one medication has been put to the test in a trial of 212 heart failure patients, in an effort to find an easier and more effective way to treat the condition. The findings were just what the scientists had hoped to see.

Scientists from the University of Minnesota have taken a monumental step toward understanding the process of abiogenesis by piecing together their own organic cell and watching it divide in two.

A once-a-day oral GLP-1 pill known as CX11 has met its dosage and efficacy goals in a trial on US patients and will now advance to its first North American Phase 3 trial. It's already cleared this final hurdle in China where it awaits approval.

After two decades in the making, scientists have cracked the code on a drug that can repair DNA, setting the scene for a new class of therapeutics that can fix tissue damage that occurs through heart attack, inflammatory disease and other conditions.

From 350,757 coin flips to prove probability to the swimming skills of dead trout, the 2024 Ig Nobel Prize winners have been recognized for their absurd work scientific research. And they all walked away with a coveted $100-trillion Zimbabwean banknote.

In what sounds more like the opening scene from a B-grade sci-fi/horror flick, head transplant operations performed entirely by AI-robot surgeons could be coming to a hospital near you within a decade, if startup BrainBridge is to have its way.

While ethical questions abound, scientists have tweaked traditional SCNT cloning of mammals to produce the very first healthy rhesus monkey that has lived to adulthood. It’s the first successful cloning of a species notoriously hard to 'copy and paste.'

Cells from two genetically distinct macaque embryos have been combined, resulting in the first chimeric primate live birth. The newborn male's green glow reveals how large a part the injected stem cells played in development, stunning scientists.